Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.
2018
KF27 .J8 115th
Available at Room 135
(request to retrieve)
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Corporate Author
Title
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017.
Imprint
Washington : U.S. Government Publishing Office, 2018.
Description
iv, 51 pages ; 24 cm
Note
Shipping list no.: 2018-0286-P.
"Serial no. 115-27."
"Serial no. 115-27."
Available in Other Form
Online version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. Antitrust concerns and the FDA approval process
Linked Resources
Call Number
KF27 .J8 115th
Language
English
GPO Item No.
1020-A
Record Appears in